France Plans €10 Billion Push To Cut Reliance On Gas and Oil France is shifting its response to rising fuel costs away from short-term relief and toward long-term electrification, according to Prime Minister Sébastien Lecornu. Instead of expanding fuel subsidies after oil prices spiked due to the Iran conflict, the government plans to redirect funding into helping households and businesses transit...
France Plans €10 Billion Push To Cut Reliance On Gas and Oil France is shifting its response to rising fuel costs away from short-term relief and toward long-term electrification, according to Prime Minister Sébastien Lecornu. Instead of expanding fuel subsidies after oil prices spiked due to the Iran conflict, the government plans to redirect funding into helping households and businesses transition to electric energy, according to Bloomberg . Under the plan, annual support for electrification will nearly double to €10 billion by 2030, up from €5.5 billion today. The increase will come from reallocating existing spending and cutting the state’s own energy use, with funds aimed at technologies like electric vehicles and heat pumps to replace gas-based systems. Lecornu emphasized that the support would be targeted at those most in need while staying consistent with France’s deficit-reduction goals. Bloomberg writes that the government is prioritizing structural change over temporary fixes, a stance Lecornu made clear by saying, “This means refusing measures that are too generous, too costly, that too often create windfall effects and sometimes rents, without resolving fundamental problems.” His comments reflect a deliberate move away from broad subsidies toward more focused, long-term investments. This marks a notable departure from 2022, when France spent tens of billions of euros cushioning consumers from energy shocks. Those measures contributed to the largest budget deficit in the eurozone and, combined with political instability, made it harder to restore fiscal balance. Rising borrowing costs have since added further pressure, with officials warning that higher bond yields linked to geopolitical tensions could increase debt servicing costs by billions. While the government had considered additional aid for workers dependent on cars, those plans were paused after a temporary drop in oil prices following a ceasefire involving Iran. Lecornu signaled that flexibili...
Luxury goods firm LVMH reported first-quarter organic revenue that missed consensus estimates, driven by the underperformance of its key fashion and leather goods division. Kering and Hermès are also due to report this week, as Bloomberg Opinion's Andrea Felsted explains. Her views are her own. (Source: Bloomberg)
Luxury goods firm LVMH reported first-quarter organic revenue that missed consensus estimates, driven by the underperformance of its key fashion and leather goods division. Kering and Hermès are also due to report this week, as Bloomberg Opinion's Andrea Felsted explains. Her views are her own. (Source: Bloomberg)
PolyPeptide Group AG and its billionaire shareholder Frederik Paulsen are working on strategic options for the company. The Swiss contract drugmaker’s review is at an early stage and “there can be no assurances” that it will result in any transaction or other outcome, the company said in a statement on Tuesday. PolyPeptide said it is “well positioned” to achieve its ambition to double 2023 revenue...
PolyPeptide Group AG and its billionaire shareholder Frederik Paulsen are working on strategic options for the company. The Swiss contract drugmaker’s review is at an early stage and “there can be no assurances” that it will result in any transaction or other outcome, the company said in a statement on Tuesday. PolyPeptide said it is “well positioned” to achieve its ambition to double 2023 revenue by 2028. PolyPeptide’s statement follows an earlier Bloomberg News report about takeover interest from private equity funds including EQT , Advent and KKR & Co. “Polypeptide takes note of recent market speculation and media reports according to which PolyPeptide has attracted takeover interest from certain investors,” it said in the statement. The company declined to comment further on the speculation. Shares of the Swiss biotech surged over 13% on Monday, the most in over two years, pushing shares to the highest level since December 2022. PolyPeptide specializes in the development and manufacturing of synthetic peptides related to metabolism, notably targeting obesity and diabetes. The biotech has been going through a turnaround which was welcomed by investors. It operates sites in Europe, the US and India and is ramping up new facilities.
Hong Kong’s tram operator has launched a new mobile app that provides real-time arrival information while pledging not to raise fares this year. Hong Kong Tramways on Tuesday announced the new app which would use location data to inform commuters of the arrival times and destinations of the next three trams at their stop. Paul Tirvaudey, managing director of Hong Kong Tramways, said the operator h...
Hong Kong’s tram operator has launched a new mobile app that provides real-time arrival information while pledging not to raise fares this year. Hong Kong Tramways on Tuesday announced the new app which would use location data to inform commuters of the arrival times and destinations of the next three trams at their stop. Paul Tirvaudey, managing director of Hong Kong Tramways, said the operator had installed more than 400 radio frequency identification (RFID) sensors along the 30km route, as...
Danske Bank A/S last year inadvertently revealed the addresses of about 20,600 of its clients to outsiders. The Danish lender “experienced an issue causing protected addresses to be visible to recipients of domestic payment transactions,” it said in a statement Tuesday. The data was only visible if recipients opened detailed payment information, and other payment types were not affected, it said, ...
Danske Bank A/S last year inadvertently revealed the addresses of about 20,600 of its clients to outsiders. The Danish lender “experienced an issue causing protected addresses to be visible to recipients of domestic payment transactions,” it said in a statement Tuesday. The data was only visible if recipients opened detailed payment information, and other payment types were not affected, it said, attributing the breach to “human error during a planned system update.” Danske first noticed the issue in October and following investigations showed that it affected a substantial number of customers. In February, the bank deleted the protected address information from transaction details within its systems. The company also asked other banks to do the same where possible, though it “has not been possible to delete the address information from documents that the banks in question have sent during the period.”
Danish drugmaker Novo Nordisk ( NVO ) on Tuesday announced a strategic partnership with OpenAI ( OPENAI ) aimed at accelerating its AI transformation in healthcare and speeding up the development of new treatment options for patients. The partnership will apply advanced AI capabilities to analyse complex datasets, identify promising drug candidates, and reduce the time required to move from resear...
Danish drugmaker Novo Nordisk ( NVO ) on Tuesday announced a strategic partnership with OpenAI ( OPENAI ) aimed at accelerating its AI transformation in healthcare and speeding up the development of new treatment options for patients. The partnership will apply advanced AI capabilities to analyse complex datasets, identify promising drug candidates, and reduce the time required to move from research to patient. It has been structured with strict data protection, governance, and human oversight to ensure ethical and compliant use, the companies said . “Integrating AI in our everyday work gives us the ability to analyse datasets at a scale that was previously impossible, identify patterns we could not see, and test hypotheses faster than ever,” said Novo Nordisk ( NVO ) CEO Mike Doustdar. OpenAI will assist Novo Nordisk in upskilling the company’s global workforce and enhancing AI literacy. The partnership will also apply OpenAI’s capabilities to improve efficiency in manufacturing, supply chain and distribution, and corporate operations. Pilot programmes will launch across research & development, manufacturing, and commercial operations, with full integration by the end of 2026. “AI is reshaping industries and in life sciences, it can help people live better, longer lives,” said Sam Altman, CEO of OpenAI ( OPENAI ). “This collaboration with Novo Nordisk will help them accelerate scientific discovery, run smarter global operations, and redefine the future of patient care.” More on Novo Nordisk A/S, OpenAI Novo Nordisk: Don't Stop Purchasing The Dip Novo Nordisk: Downgrading To 'Sell' As GLP-1 Pipeline Faces Many Risks Novo Nordisk: Competing In A Duopoly OpenAI buys AI personal finance startup Hiro Finance Claude usage more than doubles month over month while Gemini steadily climbs: BNP